Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemodynamic surrogate end-points in phase I studies?

C De Mey1

  • 1IPHAR Institute for Clinical Pharmacology, Höhenkirchen-Siegertsbrunn, Germany.

International Journal of Clinical Pharmacology and Therapeutics
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Ambroxol Lozenges in the Treatment of Acute Uncomplicated Sore Throat - a Pooled Analysis.

Drug research·2016
Same author

Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.

Drug research·2015
Same author

A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis.

Drug research·2013
Same author

Bioequivalence of a novel minitablet formulation of levetiracetam.

Arzneimittel-Forschung·2012
Same author

Nanotechnologic biosensor ellipsometry and biomarker pattern analysis in the evaluation of atherosclerotic risk profile.

Biosensors & bioelectronics·2008
Same author

Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans.

Clinical pharmacology and therapeutics·2001

Human pharmacology studies in healthy volunteers reveal drug pharmacokinetics and pharmacodynamics. These foundational studies are essential for later patient trials but cannot replace them.

Area of Science:

  • Clinical pharmacology
  • Pharmacokinetics
  • Pharmacodynamics

Background:

  • Human pharmacology studies in healthy volunteers are crucial for understanding drug behavior.
  • These studies assess drug interactions within the body's systems.
  • They provide a baseline for drug evaluation, free from disease or other medications.

Purpose of the Study:

  • To characterize the pharmacokinetic and pharmacodynamic profiles of drugs in healthy individuals.
  • To examine the relationship between drug action and the body's response in a controlled setting.
  • To establish the foundational understanding of drug behavior before patient studies.

Main Methods:

  • Conducting clinical pharmacology studies in healthy volunteers.
  • Analyzing pharmacokinetic parameters (absorption, distribution, metabolism, excretion).

Related Experiment Videos

  • Evaluating pharmacodynamic effects (drug's impact on the body).

    • Main Results:

    • Detailed characterization of drug pharmacokinetics and pharmacodynamics was achieved.
    • The interrelation between drug action and physiological response was elucidated in healthy subjects.
    • Established a comprehensive understanding of the drug's behavior in an unconfounded system.

    Conclusions:

    • Human pharmacology studies provide essential data on drug behavior.
    • These studies are a prerequisite for, but not a substitute for, patient clinical trials.
    • Understanding drug action in healthy volunteers is fundamental for assessing clinical utility in patients.